AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,281,000 | +119.7% | 806,830 | +3.1% | 0.02% | +100.0% |
| Q3 2019 | $21,977,000 | -16.6% | 782,379 | +12.4% | 0.01% | -10.0% |
| Q2 2019 | $26,347,000 | +5.9% | 695,928 | +9.2% | 0.01% | 0.0% |
| Q1 2019 | $24,875,000 | +106.9% | 637,536 | +13.0% | 0.01% | +100.0% |
| Q4 2018 | $12,025,000 | +79.3% | 564,047 | +232.9% | 0.01% | +66.7% |
| Q3 2018 | $6,708,000 | – | 169,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,485,000 | $69,804,000 | 6.41% |
| Versant Venture Management, LLC | 553,916 | $15,559,500,000 | 6.02% |
| Foresite Capital Management III, LLC | 315,331 | $8,858,000 | 3.38% |
| Opaleye Management Inc. | 285,000 | $8,006,000 | 2.90% |
| Redmile Group, LLC | 2,962,655 | $83,221,000 | 2.78% |
| Casdin Capital, LLC | 860,000 | $24,157,400,000 | 2.50% |
| Sofinnova Investments, Inc. | 933,640 | $26,226,000 | 2.37% |
| Eversept Partners, LP | 253,726 | $7,127,163 | 2.21% |
| PFM Health Sciences, LP | 2,315,938 | $65,055,000 | 1.92% |
| Global Endowment Management, LP | 581,488 | $16,334,000 | 1.43% |